1 / 1

Schmieder, R. E. (2014) How should data from SYMPLICITY HTN‑3 be interpreted?

Figure 1 Between-group differences (RDN vs control) in the change in office SBP from baseline to 6 months in African American and non-African-American patients in the SYMPLICITY HTN‑3 trial. Schmieder, R. E. (2014) How should data from SYMPLICITY HTN‑3 be interpreted?

rimona
Download Presentation

Schmieder, R. E. (2014) How should data from SYMPLICITY HTN‑3 be interpreted?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure 1 Between-group differences (RDN vs control) in the change in office SBP from baseline to 6 months in African American and non-African-American patients in the SYMPLICITY HTN‑3 trial Schmieder, R. E. (2014) How should data from SYMPLICITY HTN‑3 be interpreted? Nat. Rev. Cardiol. doi:10.1038/nrcardio.2014.70

More Related